Antibodies

Items 51-60 of 539

per page
Set Descending Direction
  1. anti-Asprosin, mAb (Birdy-1)
    AG-20B-0073
    AG-20B-0073-C100100 µg
    CHF 440.00
  2. anti-BAFF (human), mAb (2.81)
    AG-20B-0018
    AG-20B-0018-C100100 µg
    CHF 460.00
  3. anti-BAFF (human), mAb (blocking) (4.62)
    AG-20B-0017
    AG-20B-0017-C100100 µg
    CHF 460.00
  4. anti-BAFF (human), mAb (blocking) (4.62) (Biotin)
    AG-20B-0017B
    AG-20B-0017B-C100100 µg
    CHF 490.00
  5. anti-Betatrophin (human), pAb (IN108)
    AG-25B-0033
    AG-25B-0033-C100100 µg
    CHF 190.00
  6. anti-BimS/EL/L, mAb (10B12)
    AG-20T-0143
    AG-20T-0143-C100100 µg
    CHF 420.00
    Flow cytometry data in permeabilized and fixed transfected cells using anti-Bim, mAb (10B12) (Prod. No. AG-20T-0143), anti-EE (positive control) or secondary antibody alone (negative control). Staining was visualised by FITC-conjugated goat anti-rat or an
  7. anti-BimS/EL/L, mAb (3C5)
    AG-20T-0142
    AG-20T-0142-C100100 µg
    CHF 420.00
    Flow cytometry data in permeabilized and fixed transfected cells using anti-Bim, mAb (3C5) (Prod. No. AG-20T-0142), anti-EE (positive control) or secondary antibody alone (negative control). Staining was visualised by FITC-conjugated goat anti-rat or anti
  8. anti-BRAF (V600E) (human), Rabbit Monoclonal (RM8) (Biotin)
    REV-31-1042-02
    REV-31-1042-02-C05050 µg
    CHF 838.00
    anti-BRAF (V600E) (human), Rabbit Monoclonal (RM8) (Biotin)
  9. anti-BTLA (human), mAb (6F4)
    AG-20B-0049
    AG-20B-0049-C100100 µg
    CHF 430.00
  10. anti-Calreticulin (human), mAb (CR213-2AG)
    AG-20A-0079
    AG-20A-0079-C05050 µg
    CHF 270.00
    AG-20A-0079-C100100 µg
    CHF 350.00
    Western blot analysis using anti-Calreticulin (human), mAb (CR213-2AG) (Prod. No. AG-20A-0079) at 1:2'000 dilution.1: Human Calreticulin (His-tagged).2: HEK 293T cell lysates (100μg).3: HepG2 cell lysates (100μg).4: THP1 cell

Items 51-60 of 539

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.